CARECLOUD INC - MTBC 11 PERP (MTBCP) Fundamental Analysis & Valuation

NASDAQ:MTBCP • US14167R2094

26.9137 USD
-0.08 (-0.28%)
Last: Jan 9, 2023, 08:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MTBCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

MTBCP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. While MTBCP seems to be doing ok healthwise, there are quite some concerns on its profitability. MTBCP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. MTBCP Profitability Analysis

1.1 Basic Checks

  • In the past year MTBCP has reported negative net income.
  • In the past year MTBCP had a positive cash flow from operations.
MTBCP Yearly Net Income VS EBIT VS OCF VS FCFMTBCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M -20M

1.2 Ratios

  • MTBCP has negative profitability rations, so we won't be analyzing them here.
  • The Return On Invested Capital of MTBCP (4.81%) is better than 84.44% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 4.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTBCP Yearly ROA, ROE, ROICMTBCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

1.3 Margins

  • MTBCP's Operating Margin of 3.77% is fine compared to the rest of the industry. MTBCP outperforms 73.33% of its industry peers.
  • The Gross Margin of MTBCP (38.04%) is worse than 66.67% of its industry peers.
  • MTBCP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.77%
PM (TTM) N/A
GM 38.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
MTBCP Yearly Profit, Operating, Gross MarginsMTBCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MTBCP Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTBCP is destroying value.
  • The number of shares outstanding for MTBCP has been increased compared to 1 year ago.
  • MTBCP has a worse debt/assets ratio than last year.
MTBCP Yearly Shares OutstandingMTBCP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M
MTBCP Yearly Total Debt VS Total AssetsMTBCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50M 100M

2.2 Solvency

  • An Altman-Z score of 9.66 indicates that MTBCP is not in any danger for bankruptcy at the moment.
  • MTBCP's Altman-Z score of 9.66 is amongst the best of the industry. MTBCP outperforms 88.89% of its industry peers.
  • The Debt to FCF ratio of MTBCP is 0.06, which is an excellent value as it means it would take MTBCP, only 0.06 years of fcf income to pay off all of its debts.
  • MTBCP has a Debt to FCF ratio of 0.06. This is amongst the best in the industry. MTBCP outperforms 82.22% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that MTBCP is not too dependend on debt financing.
  • MTBCP has a better Debt to Equity ratio (0.00) than 64.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Altman-Z 9.66
ROIC/WACC0.6
WACC8.03%
MTBCP Yearly LT Debt VS Equity VS FCFMTBCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • MTBCP has a Current Ratio of 1.21. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.21, MTBCP is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.19 indicates that MTBCP should not have too much problems paying its short term obligations.
  • MTBCP's Quick ratio of 1.19 is on the low side compared to the rest of the industry. MTBCP is outperformed by 71.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.19
MTBCP Yearly Current Assets VS Current LiabilitesMTBCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MTBCP Growth Analysis

3.1 Past

  • MTBCP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.73%, which is quite impressive.
  • MTBCP shows a small growth in Revenue. In the last year, the Revenue has grown by 7.14%.
  • MTBCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.63% yearly.
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%

3.2 Future

  • Based on estimates for the next years, MTBCP will show a small growth in Earnings Per Share. The EPS will grow by 6.25% on average per year.
  • The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MTBCP Yearly Revenue VS EstimatesMTBCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MTBCP Yearly EPS VS EstimatesMTBCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. MTBCP Valuation Analysis

4.1 Price/Earnings Ratio

  • MTBCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MTBCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTBCP Price Earnings VS Forward Price EarningsMTBCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

  • MTBCP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MTBCP is cheaper than 84.44% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, MTBCP is valued a bit cheaper than 71.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.5
EV/EBITDA 23.41
MTBCP Per share dataMTBCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • MTBCP's earnings are expected to grow with 16.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.89%
EPS Next 3Y16.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MTBCP Dividend Analysis

5.1 Amount

  • No dividends for MTBCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MTBCP Fundamentals: All Metrics, Ratios and Statistics

CARECLOUD INC - MTBC 11 PERP

NASDAQ:MTBCP (1/9/2023, 8:23:58 PM)

26.9137

-0.08 (-0.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-03
Earnings (Next)03-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap409.63M
Revenue(TTM)143.75M
Net Income(TTM)-6.85M
Analysts83.64
Price Target76.1 (182.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-220.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.24%
Min EPS beat(2)4.61%
Max EPS beat(2)61.87%
EPS beat(4)4
Avg EPS beat(4)48.06%
Min EPS beat(4)4.61%
Max EPS beat(4)94.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.43%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.85
P/FCF 46.5
P/OCF 19.3
P/B 3.98
P/tB 34.48
EV/EBITDA 23.41
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.58
FCFY2.15%
OCF(TTM)1.39
OCFY5.18%
SpS9.44
BVpS6.76
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 4.81%
ROICexc 4.99%
ROICexgc 43.34%
OM 3.77%
PM (TTM) N/A
GM 38.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Debt/EBITDA 0.03
Cap/Depr 103.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.19
Altman-Z 9.66
F-Score4
WACC8.03%
ROIC/WACC0.6
Cap/Depr(3y)81.08%
Cap/Depr(5y)58.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
EBIT growth 1Y261.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1308.1%
EBIT Next 3Y177.57%
EBIT Next 5Y93.09%
FCF growth 1Y213.67%
FCF growth 3Y-21.74%
FCF growth 5YN/A
OCF growth 1Y1553.9%
OCF growth 3Y25.1%
OCF growth 5YN/A

CARECLOUD INC - MTBC 11 PERP / MTBCP FAQ

What is the ChartMill fundamental rating of CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MTBCP.


Can you provide the valuation status for CARECLOUD INC - MTBC 11 PERP?

ChartMill assigns a valuation rating of 1 / 10 to CARECLOUD INC - MTBC 11 PERP (MTBCP). This can be considered as Overvalued.


Can you provide the profitability details for CARECLOUD INC - MTBC 11 PERP?

CARECLOUD INC - MTBC 11 PERP (MTBCP) has a profitability rating of 1 / 10.


What is the expected EPS growth for CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?

The Earnings per Share (EPS) of CARECLOUD INC - MTBC 11 PERP (MTBCP) is expected to grow by 13.69% in the next year.